Weill Cancer Hub East established to investigate interplay between nutrition, metabolism, and immunotherapy

Neoadjuvant dostarlimab averts brutal surgery in 80% of patients with dMMR solid tumors

Three years ago, researchers from Memorial Sloan Kettering Cancer Center published stunning results: For the 5% of rectal cancer patients whose tumors are mismatch-repair deficient, neoadjuvant dostarlimab-gxly (Jemperli) has the makings of a silver bullet.

Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertile
Six years later, she is well—and pregnant with her third child

When Kelly Spill was eight months pregnant, she experienced some constipation and noticed blood in her stool. Her OBGYN wasn’t worried.

TIL + pembro regimen achieves 24% response rate in solid epithelial tumors, marking a step forward in immunotherapy research

Immunotherapy has changed the course of blood cancers and melanomas, but is stubbornly ineffective for the treatment of most epithelial solid cancers—the cancers that kill about 90% of the more than 600,000 Americans who die of cancer each year.

USC Norris opens Keck Medicine of USC–Newport Beach Radiation Oncology and Imaging center

USC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, has opened Keck Medicine of USC–Newport Beach Radiation Oncology and Imaging, a new radiation oncology and imaging center, at 4590 MacArthur Blvd. in Newport Beach, CA.

April 18, 2025

Vol.51 No.15

Conversation with The Cancer Letter

Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy

After Karen Knudsen departed from the American Cancer Society late last year, the question of where she will end up becoming the fodder for cocktail party chatter throughout oncology.

MD Anderson breaks ground on new Houston-area cancer center

The University of Texas MD Anderson Cancer Center on March 31 broke ground on a new 470,000-square-foot facility in Sugar Land, bringing a range of cancer services closer to those living in Southwest Houston and the surrounding areas.

April 04, 2025

Vol.51 No.13

Weill Cancer Hub East established to investigate interplay between nutrition, metabolism, and immunotherapy

YOU MAY BE INTERESTED IN

Neoadjuvant dostarlimab averts brutal surgery in 80% of patients with dMMR solid tumors

Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertile
Six years later, she is well—and pregnant with her third child

TIL + pembro regimen achieves 24% response rate in solid epithelial tumors, marking a step forward in immunotherapy research

USC Norris opens Keck Medicine of USC–Newport Beach Radiation Oncology and Imaging center

Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy

MD Anderson breaks ground on new Houston-area cancer center

Renew today!

Subscriber content

Never miss an issue!

Login

Weill Cancer Hub East established to investigate interplay between nutrition, metabolism, and immunotherapy

YOU MAY BE INTERESTED IN

Neoadjuvant dostarlimab averts brutal surgery in 80% of patients with dMMR solid tumors

Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertileSix years later, she is well—and pregnant with her third child

TIL + pembro regimen achieves 24% response rate in solid epithelial tumors, marking a step forward in immunotherapy research

USC Norris opens Keck Medicine of USC–Newport Beach Radiation Oncology and Imaging center

Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy

MD Anderson breaks ground on new Houston-area cancer center

Never miss an issue!

Login

Kelly Spill opted for dostarlimab trial, avoiding rectal cancer treatment that would leave her infertile
Six years later, she is well—and pregnant with her third child